相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hematopoietic Cell Transplantation from an HLA-Mismatched Familial Donor Is Feasible Without Ex Vivo-T Cell Depletion after Reduced-intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin
Kyoo-Hyung Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
Jumei Shi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation
Astrid Schulze et al.
EXPERIMENTAL HEMATOLOGY (2008)
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors
Andreas Lundqvist et al.
BLOOD (2007)
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation
Xiao-Jun Huang et al.
HAEMATOLOGICA (2007)
Partially matched, nonmyeloablative allogeneic transplantation: Clinical outcomes and immune reconstitution
David A. Rizzieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning
Hiroyasu Ogawa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
KIR Ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
Katharine C. Hsu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
X. -J. Huang et al.
BONE MARROW TRANSPLANTATION (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Cyclosporin A regulates human NK cell apoptosis induced by soluble HLA-1 or by target cells
A Poggi et al.
AUTOIMMUNITY REVIEWS (2005)
In vivo alemtuzumab enables haploidentical human leukocyte antigen-mismatched hematopoietic stem-cell transplantation without ex vivo graft manipulation
Y Kanda et al.
TRANSPLANTATION (2005)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
VDUP1 is required for the development of natural killer cells
KN Lee et al.
IMMUNITY (2005)
Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation
JR Passweg et al.
LEUKEMIA (2004)
Alloreactive killer cells: Hindrance and help for haematopoietic transplants
P Parham et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study
P Lewalle et al.
BONE MARROW TRANSPLANTATION (2003)
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect
SS Farag et al.
BLOOD (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)